The Neurobiology of
Suicidal Behavior
|
|
|
J. John Mann, MD
Chief, Department of
Neuroscience
New York State Psychiatric Institute
Professor of Psychiatry and
Radiology |
|
College of Physicians and Surgeons
of Columbia University |
Suicidal Behavior
|
|
|
Is not a normal response to stress. |
|
It is a complication of psychiatric
illness in the vulnerable person. |
|
The commonest illness associated with
suicide or suicide attempts is recurrent unipolar depression. |
|
Psychiatric illness can and does lead
to social crises. |
|
Social crises can trigger suicide in
the context of psychiatric illness. |
|
|
Suicidal Behavior
|
|
|
Prevention starts with recognition of
psychiatric illnesses associated with the highest risk of suicidal behavior
and then recognition of individual patients at higher risk. |
|
Patients at higher risk have a
predisposition. |
|
Treatment of psychiatric illness will
reduce suicide rates. |
|
Reduction of the predisposition will
reduce risk. |
Magnitude of the Problem
|
|
|
One million suicides per year world
wide |
|
10-20 times more suicide attempts |
|
3rd leading cause of death in 15-34
year olds in the USA |
|
Leading cause of death in youth in
China, Sweden, Australia and New Zealand |
|
286,000 suicides per yr in China,
leading cause of death in 15-34 year olds. |
Demographics
|
|
|
Women make more attempts than men. |
|
Men commit suicide at 4 times the rate
of women in the USA. |
|
Young people make more attempts than
older folks. |
|
Older people make more lethal suicide
attempts. |
Relationship to Psychiatric
Illness
|
|
|
Psychological autopsies in completed
suicides confirm that over 90% have a diagnosable psychiatric illness. |
|
Life-time mortality due to suicide in
previously hospitalized patients are high: unipolar depression (15%); bipolar
disorder (15-20%); alcoholics (18%); schizophrenics (10-15%); and borderline
and antisocial personality disorders (5-10%). |
|
Comorbidity increases risk. |
Vulnerability or Diathesis
for Suicidal Behavior
|
|
|
Most patients with psychiatric
disorders including mood disorders do not attempt suicide. |
|
What determines whether a patient with
major depression will attempt or complete suicide? |
|
At risk patients have a vulnerability
or predisposition to suicidal behavior under circumstances of a psychiatric
illness. |
|
What is this vulnerability or
diathesis? |
Vulnerability or Diathesis
for Suicidal Behavior
|
|
|
Impulsivity related to probability. |
|
Hopelessness or pessimism related to
probability. |
|
Suicidal intent related to lethality. |
|
Diathesis is transmitted in families
and has biological correlates. |
|
|
A Stress Diathesis Model
|
|
|
Stressors include an acute psychiatric
illness such as a major depressive episode or psychosocial crisis. |
|
The stressor is not enough. There must
be a diathesis or predisposition. |
|
Components of the diathesis include
impulsivity, hopelessness or pessimism and intent. |
|
The best clinical clue to the presence
of a diathesis is a history of a suicide attempt. |
Slide 10
Where Does Neurobiology Fit
In?
|
|
|
Psychiatric illnesses involve brain
biology. |
|
The diathesis or vulnerability to
suicidal behavior involves different brain biology. |
|
Parts of the brain biology related to
components of vulnerability such as aggression/impulsivity, suicide intent or
hopelessness have been identified. |
Serotonergic Activity is
Related to Aggression/Impulsivity and Suicidal Behavior
|
|
|
There is a trait deficiency of
serotonin function proportional to seriousness of suicidal acts that predicts
future suicide. |
|
Low serotonin is proportional to
seriousness of externally directed aggression and can predict future
aggression. |
|
Low serotonin function modulates the
intent and impulsive aspects of the suicidal behavior predisposition. |
Norepinephrine Relates to
Hopelessness
|
|
|
Hopelessness predicts future suicide. |
|
Suicide attempters feel more hopeless
and perceive fewer reasons for living than other patients in the face of
equivalent psychiatric illness or adverse life events. |
|
Inescapable restraint in rats depletes
norepinephrine and can generate despair and giving up. |
|
Suicide victims have evidence of marked
stress responses in the brain norepinephrine system. |
|
Perhaps hopelessness results from NE
depletion? |
Mapping the Pathobiology of
Depression and Suicide
|
|
|
This approach tells us what parts of
the brain is involved in the pathobiology of depression and the
predisposition for suicide. |
|
Postmortem brain receptor maps. |
|
In vivo brain receptor mapping. |
Serotonin System
Dysfunction: Independent correlations with
suicidal behavior and depression
|
|
|
Deficient serotonergic
neurotransmission has been hypothesized as a cause of major depression for 30
years. Depression is a complex disorder and involves many brain regions. |
|
Deficient serotonergic function is also
associated with suicidal behavior. Suicidal behavior involves a basic
decision regarding life or death, likely involving a small part of the brain. |
Markers of Serotonin Input:
Presynaptic markers
|
|
|
The serotonin transporter is located on
serotonin nerve terminals and is an index of serotonin function or input. |
|
It can be quantified by a radiolabeled
SSRI in both post-mortem tissue from deceased patients and more recently in
living patients using devices like the PET scanner. |
|
|
Postmortem Cortical Brain
Mapping in Suicide and Depression
|
|
|
Lower serotonin transporter binding in
Major Depression is widespread in PFC. |
|
Lower serotonin transporter binding in suicide
is highly localized to ventro-medial PFC. |
|
The ventro-medial prefrontal cortex is
involved in behavioral and cognitive restraint. Therefore, deficient
serotonin input to that brain region could predispose to acting on suicidal
or aggressive feelings. |
Serotonin Responsivity
|
|
|
Can be assessed by |
|
Using a PET scanner to study changes in
regional brain neuronal activity using glucose uptake to determine the brain
regions involved in depression and in suicidal acts. |
PET Measures of PFC
Activity and Depression or Suicidal Behavior
|
|
|
Widespread altered activity in the PFC
is associated with depression. |
|
Localized medial PFC hypo-function in
suicide attempters is proportional to the medical lethality of the most
lethal life-time suicide attempt. |
|
The activity in this brain region is
independent of the objective severity of the depression, but is related to impulsivity
and suicidal intent. Thus, it can influence suicidal behavior. |
|
|
Why are Serotonin Responses
Abnormal in that Part of the Brain?
|
|
|
In depression there are fewer neurons
in many areas of the prefrontal cortex, hippocampus and anterior cingulate. |
|
In suicide there is less serotonin
input to each neuron in ventro-medial prefrontal cortex. |
|
Thus, the function of this area is
doubly compromised. |
Factors Influencing
Suicide
Diathesis or Predisposition and Serotonin
|
|
|
Genetics |
|
Stress |
|
Sex |
|
Parenting |
|
Age |
Familial Transmission of
Suicidal Behavior
|
|
|
Genetic factors. |
|
|
|
Non-genetic factors. |
Genetics of Suicide
|
|
|
Adoption studies show a 6- to 15-fold
increased risk. |
|
Twin studies show that 55% of the
variance in suicidal behavior can be explained by genetic factors. |
|
Family studies show a 4- to 10-fold
increased risk for suicidal behavior in first-degree relatives. |
|
Genetic effects on suicide risk are
comparable to bipolar disorder and schizophrenia. |
Candidate Genes
From the Serotonin System in Suicide
|
|
|
Serotonin transporter. |
|
Tryptophan hydroxylase. |
|
Receptors including 5-HT1A,
5-HT1B, and 5-HT2A. |
|
Results are promising but preliminary. |
|
Imply cause and mechanism. |
|
Genome screen to search for more
candidate genes. |
Life Events or Stress and
Suicide
|
|
|
Life events are more common in patients
with mood disorders compared to healthy controls. |
|
Suicide attempters are more hopeless
and perceive fewer reasons for living given an equivalent number of life
events compared with psychiatric controls. |
|
Life events may trigger a suicide
attempt in vulnerable individuals. Serotonin transporter gene variant
modulates the susceptibility to life events. |
|
|
Slide 26
Slide 27
Neurobiology of Suicide
Looks like a Stress Response
|
|
|
Stress hormones cortisol and CRF are
elevated in blood or CSF of suicide attempters of future suicides. |
|
Fewer prefrontal CRF receptors in
suicide victims suggest excess CRF release. |
|
Evidence in brain of suicides of more NE
release (more tyrosine hydroxylase and beta-adrenergic desentization ). |
|
Abuse history in childhood associated
with excessive adult stress responses in terms of both cortisol and NE. |
|
Fewer noradrenergic neurons in
depressed suicides means lower functional capacity and prone to NE depletion. |
|
Low norepinephrine may favor more pessimism. |
Parenting, Suicide and
Psychopathology
|
|
|
Parental abuse is independently
associated with depression, impulsiveness and suicide attempts in adulthood. |
|
Abuse in childhood may affect suicidal
behavior in adulthood due to more trait impulsivity (less serotonin). |
|
Maternal deprivation in monkeys resets serotonin
system function downwards; deficiency persists into adulthood and is
associated with more impulsive, aggressive behavior in adulthood. |
Drug Abuse and Suicide
|
|
|
Alcoholism, drug use disorders and
cigarette smoking are all associated with higher suicide rates. |
|
Low serotonin activity may favor
addictive behaviors and independently predispose to suicidal and aggressive
acts. |
|
Some drugs can deplete or lower
serotonin further. |
Slide 31
Summary
|
|
|
Suicide occurs in the context of
depression, stress, hopelessness and suicidal ideation. |
|
Impaired serotonergic transmission in
the ventral prefrontal cortex predisposes some patients to act on suicidal
ideation. |
|
Stress leads to norepinephrine
depletion and may explain excessive hopelessness and thereby favor suicidal
ideation and suicidal behavior. |
The Future
|
|
|
Better prediction of risk. |
|
Treat more people with psychiatric
illness. |
|
Develop medication and
psychotherapeutic interventions to reduce predisposition to suicidal
behavior. Lithium and clozapine are promising anti-suicidal treatments. |
|
Reduce familial transmission of
predisposition to suicidal behavior. |